首頁 › 膽道系統癌症 › 紐約州 › New York City
New York City, NY 的 膽道系統癌症 臨床試驗
10 項針對 膽道系統癌症 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
招募中3 期
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
招募中3 期
- Research Site, New York
- Research Site, New York
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
招募中1/2 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0324), New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
招募中3 期
- Memorial Sloan Kettering Cancer Centers, New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
招募中1 期
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
其他城市的 膽道系統癌症 試驗
- Houston, TX18 項研究
- Los Angeles, CA11 項研究
- Boston, MA11 項研究
- Nashville, TN9 項研究
- Baltimore, MD8 項研究
- San Antonio, TX8 項研究
- Washington, DC7 項研究
- Arlington, VA7 項研究
- Pittsburgh, PA7 項研究
- Madison, WI6 項研究
- Dallas, TX6 項研究
- Cleveland, OH6 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。